Glycomics/Glycobiology Market Size

Glycomics/Glycobiology Market size was over USD 1.71 billion in 2022 and is anticipated to cross USD 8.57 billion by 2035, growing at more than 13.2% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of glycomics/glycobiology is estimated at USD 1.89 billion.

The global market is projected to witness significant growth over the forecast period on account of escalating research & development expenditure by pharmaceutical companies coupled with an increment of chronic diseases such as cancer and diabetes. According to the World Health Organization, the global cancer burden raised to 18.1 million cases and 9.6 million deaths in 2018, and approximately 70% of deaths from cancer occur in low-income and middle-income countries. Additionally, factors such as availability of products to conduct protocol with high specificity and sensitivity, funding through government bodies, and continuous technological advancements are estimated to support the development of the market over the forecast period.